Transpupillary thermotherapy for subfoveal neovascularization secondary to group 2A idiopathic juxtafoveolar telangiectasis.
OBJECTIVE
To evaluate the efficacy and safety of transpupillary thermotherapy (TTT) for subfoveal neovascularization (SRNVM) in patients with group 2A Idiopathic Juxtafoveolar Telangiectasis (IJFT).


METHODS
Nonrandomized interventional case series.


METHODS
We performed TTT for subfoveal SRNVM in 14 eyes of 13 patients with group 2A IJFT, who were referred to our tertiary care center. We evaluated visual outcome and SRNVM closure rate in these patients.


RESULTS
After a mean follow-up period of 8.65 months, 92.3% of treated eyes had stabilization or improvement in visual acuity as well as regression of SRNVM by fluorescein angiography (FA). One SRNVM showed persistent leakage. One patient worsened by more than 2 Snellen lines; one required retreatment.


CONCLUSIONS
Transpupillary thermotherapy may be a safe and useful alternative treatment option for patients with group 2A IJFT with subfoveal SRNVM.
Shukla
Dhananjay
D
Retina-Vitreous Service, Aravind Eye Hospital & Postgraduate Institute of Ophthalmology, 1 Anna Nagar, Madurai 625-020, Tamil Nadu, India. daksh@aravind.org
Singh
Jatinder
J
Kolluru
Chandra Mohan
CM
Kim
Ramasamy
R
Namperumalsamy
Perumalsamy
P
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005451:Fluorescein Angiography; D005584:Fovea Centralis; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011680:Pupil; D015861:Retinal Neovascularization / Q000209:etiology / Q000628:therapy*; D012171:Retinal Vessels / Q000473:pathology*; D013684:Telangiectasis / Q000150:complications / Q000628:therapy*; D014792:Visual Acuity